phenylhydroxylamine has been researched along with Degenerative Diseases, Central Nervous System in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahuja, M; Ben Aissa, M; Bourassa, MW; Gaisin, A; Gaisina, IN; Gazaryan, IG; Kaidery, NA; Lee, SH; Nikulin, SV; Poloznikov, AA; Ratan, RR; Smirnova, NN; Thatcher, GRJ; Thomas, B; Wakade, S | 1 |
1 other study(ies) available for phenylhydroxylamine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors.
Topics: Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Hydroxylamines; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress | 2018 |